ArticleOncogene2014

MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.

Y Xiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.